Veena Shankaran1, Joseph M Unger2, Amy K Darke2, Dawn L Hershman3, Scott D Ramsey4. 1. Fred Hutchinson Cancer Research Center, Seattle, WA, United States of America; University of Washington, Department of Medicine, Seattle, WA, United States of America. Electronic address: vshank@uw.edu. 2. Fred Hutchinson Cancer Research Center, Seattle, WA, United States of America; SWOG Statistics and Data Management Center, Seattle, WA, United States of America. 3. Columbia University, New York, NY, United States of America. 4. Fred Hutchinson Cancer Research Center, Seattle, WA, United States of America; University of Washington, Department of Medicine, Seattle, WA, United States of America.
Abstract
BACKGROUND: Few studies have assessed the financial impact of cancer diagnosis on patients and caregivers in diverse clinical settings. S1417CD, led by the SWOG Cancer Research Network, is the first prospective longitudinal cohort study assessing financial outcomes conducted in the NCI Community Oncology Research Program (NCORP). We report our experience navigating design and implementation barriers. METHODS: Patients age ≥ 18 within 120 days of metastatic colorectal cancer diagnosis were considered eligible and invited to identify a caregiver to participate in an optional substudy. Measures include 1) patient and caregiver surveys assessing financial status, caregiver burden, and quality of life and 2) patient credit reports obtained from the credit agency TransUnion through a linkage requiring social security numbers and secure data transfer processes. The primary endpoint is incidence of treatment-related financial hardship, defined as one or more of the following: debt accrual, selling or refinancing home, ≥20% income decline, or borrowing money. Accrual goal was n = 374 patients in 3 years. RESULTS: S1417CD activated on Apr 1, 2016 and closed on Feb 1, 2019 after reaching its accrual goal sooner than anticipated. A total of 380 patients (median age 59.7 years) and 155 caregivers enrolled across 548 clinical sites. Credit data were not obtainable for 76 (20%) patients due to early death, lack of credit, or inability to match records. CONCLUSIONS: Robust accrual to S1417CD demonstrates patients' and caregivers' willingness to improve understanding of financial toxicity despite perceived barriers such as embarrassment and fears that disclosing financial status could influence treatment recommendations.
BACKGROUND: Few studies have assessed the financial impact of cancer diagnosis on patients and caregivers in diverse clinical settings. S1417CD, led by the SWOG Cancer Research Network, is the first prospective longitudinal cohort study assessing financial outcomes conducted in the NCI Community Oncology Research Program (NCORP). We report our experience navigating design and implementation barriers. METHODS:Patients age ≥ 18 within 120 days of metastatic colorectal cancer diagnosis were considered eligible and invited to identify a caregiver to participate in an optional substudy. Measures include 1) patient and caregiver surveys assessing financial status, caregiver burden, and quality of life and 2) patient credit reports obtained from the credit agency TransUnion through a linkage requiring social security numbers and secure data transfer processes. The primary endpoint is incidence of treatment-related financial hardship, defined as one or more of the following: debt accrual, selling or refinancing home, ≥20% income decline, or borrowing money. Accrual goal was n = 374 patients in 3 years. RESULTS:S1417CD activated on Apr 1, 2016 and closed on Feb 1, 2019 after reaching its accrual goal sooner than anticipated. A total of 380 patients (median age 59.7 years) and 155 caregivers enrolled across 548 clinical sites. Credit data were not obtainable for 76 (20%) patients due to early death, lack of credit, or inability to match records. CONCLUSIONS: Robust accrual to S1417CD demonstrates patients' and caregivers' willingness to improve understanding of financial toxicity despite perceived barriers such as embarrassment and fears that disclosing financial status could influence treatment recommendations.
Authors: Amy Finkelstein; Sarah Taubman; Bill Wright; Mira Bernstein; Jonathan Gruber; Joseph P Newhouse; Heidi Allen; Katherine Baicker Journal: Q J Econ Date: 2012-05-03
Authors: Matthew P Banegas; Gery P Guy; Janet S de Moor; Donatus U Ekwueme; Katherine S Virgo; Erin E Kent; Stephanie Nutt; Zhiyuan Zheng; Ruth Rechis; K Robin Yabroff Journal: Health Aff (Millwood) Date: 2016-01 Impact factor: 6.301
Authors: K Robin Yabroff; Emily C Dowling; Gery P Guy; Matthew P Banegas; Amy Davidoff; Xuesong Han; Katherine S Virgo; Timothy S McNeel; Neetu Chawla; Danielle Blanch-Hartigan; Erin E Kent; Chunyu Li; Juan L Rodriguez; Janet S de Moor; Zhiyuan Zheng; Ahmedin Jemal; Donatus U Ekwueme Journal: J Clin Oncol Date: 2015-12-07 Impact factor: 44.544
Authors: Neal J Meropol; Deborah Schrag; Thomas J Smith; Therese M Mulvey; Robert M Langdon; Diane Blum; Peter A Ubel; Lowell E Schnipper Journal: J Clin Oncol Date: 2009-07-06 Impact factor: 44.544
Authors: Bruce J Giantonio; Paul J Catalano; Neal J Meropol; Peter J O'Dwyer; Edith P Mitchell; Steven R Alberts; Michael A Schwartz; Al B Benson Journal: J Clin Oncol Date: 2007-04-20 Impact factor: 44.544
Authors: Scott D Ramsey; Aasthaa Bansal; Catherine R Fedorenko; David K Blough; Karen A Overstreet; Veena Shankaran; Polly Newcomb Journal: J Clin Oncol Date: 2016-01-25 Impact factor: 44.544
Authors: Veena Shankaran; Joseph M Unger; Amy K Darke; Jennifer Marie Suga; James L Wade; Peter J Kourlas; Sreenivasa R Chandana; Mark A O'Rourke; Suma Satti; Diane Liggett; Dawn L Hershman; Scott D Ramsey Journal: J Natl Cancer Inst Date: 2022-03-08 Impact factor: 13.506